<p>不到两周前，华尔街和投资者获得了第四季度最重要的数据发布之一——不，我不是在说十月份的通胀报告。</p>
<p>在一个季度结束后的 45 天内，管理资产至少为 1 亿美元的机构投资者必须向证券交易委员会提交 13F 表格。13F 为普通投资者提供了一种跟踪华尔街顶级资金经理在上一个季度（在这种情况下是截至九月的季度）购买和出售哪些股票的方式。</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy83OTg4NTEvbW9uZXktbWFuYWdlci1zdG9jay1jaGFydC1tYXJrZXQtbGV2ZWwtMi1kYXRhLWludmVzdC1nZXR0eS5qcGcmdz03MDA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy83OTg4NTEvbW9uZXktbWFuYWdlci1zdG9jay1jaGFydC1tYXJrZXQtbGV2ZWwtMi1kYXRhLWludmVzdC1nZXR0eS5qcGcmdz03MDA"/></p>
<p>图片来源：Getty Images。</p>
<p>虽然 13F 申报季的亮点往往是沃伦·巴菲特的 <strong>伯克希尔哈撒韦</strong>，但多年来在华尔街上令人瞩目的亿万富翁投资者并不少见。亿万富翁以色列·英格兰德（Israel Englander）是千禧管理公司（Millennium Management）的创始人，管理着近 2110 亿美元的资产，分散在数千种证券（普通股和期权）中，是一个完美的例子。</p>
<p>在英格兰德及其顶级顾问进行的数千笔交易中，有两笔逆向交易尤为突出。在某种程度上，英格兰德一直是华尔街顶级人工智能（AI）股票 <strong>英伟达</strong>（Nvidia）的果断卖家。相比之下，他则在大量购买一只挣扎中的医疗保健股票，该股票的股息收益率接近火热的 12%！</p>
<h2>英格兰德的千禧管理公司出售超过三分之二的英伟达股票</h2>
<p>自 2023 年开始以来，人工智能巨头英伟达几乎势不可挡。截至 11 月 22 日收盘，股价上涨了 871%，公司的市值超过 3.1 万亿美元。华尔街从未见过如此迅速增长的市场领先企业。也许这就是千禧管理公司出售股票的动力。</p>
<p>根据 13F 申报，英格兰德的基金在截至 9 月 30 日的过去一年中出售了 26,371,575 股经过拆分调整的英伟达股票。这里的 “拆分调整” 是指英伟达在 6 月 7 日交易结束后进行了一次历史性的 10 比 1 的股票拆分。千禧管理公司剩余的 1115 万股英伟达股票意味着其持仓在一年内减少了 70%。</p>
<p>英伟达的成功得益于其在 AI 加速数据中心的主导地位。该公司的 H100 图形处理单元（GPU）和下一代 Blackwell 芯片的需求超出了供应，导致了卓越的定价能力和惊人的 74.6% 的毛利率，截至 2024 财年第三季度（10 月 27 日）。</p>
<p>更重要的是，英伟达的 GPU 在计算能力方面证明了其整体优越性。由于英伟达的 CUDA 软件平台使客户忠于其生态系统，并且其 GPU 在计算性能上表现优异，因此它在超越华尔街已经高涨的共识增长预测方面没有遇到太大困难。</p>
<p>但对于英伟达来说，可能正在酝酿一场完美风暴，这或许可以解释英格兰德在华尔街的 AI 宠儿中持续的卖出活动。</p>
<p>英伟达股票见顶的一个重要线索是其毛利率。虽然 AI-GPU 的稀缺性和 H100 的高价使公司的毛利率在财年第一季度飙升至超过 78%，但随后在第二季度回落至 75.1%，在最新季度降至 74.6%。英伟达对财年第四季度的预测将其毛利率定在 73% 到 73.5% 之间，波动幅度为±50 个基点。这一毛利率的持续下降意味着 AI-GPU 的稀缺性正在减弱，英伟达的定价能力也在下降。</p>
<p>竞争也从各个角度向英伟达袭来。尽管 <strong>超微半导体</strong>（Advanced Micro Devices）等直接竞争对手获得了大部分关注，但对英伟达数据中心 “房地产” 的更大威胁可能来自内部。许多按净销售额计算的顶级客户，属于 “七大奇迹” 之一，正在内部开发 AI-GPU 以在其数据中心使用。即使英伟达的芯片在计算能力上具有优势，这些内部开发的芯片也更便宜且更易于获取。</p>
<p>历史可能是促使英格兰德兑现收益的另一个催化剂。在过去三十年中，我们从未见过任何可能改变游戏规则的技术避免早期泡沫。互联网、基因解码、3D 打印和元宇宙只是一些备受推崇的进步的例子，投资者高估了它们在早期阶段的实用性和采用率。如果历史重演，人工智能泡沫破裂，没有哪家公司会比英伟达更受影响。</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy83OTg4NTEvcGhhcm1hY3ktY3VzdG9tZXItcHJlc2NyaXB0aW9uLW1lZGljaW5lLWluc3VyYW5jZS1obW8taGVhbHRoY2FyZS1nZXR0eS5qcGcmdz03MDA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy83OTg4NTEvcGhhcm1hY3ktY3VzdG9tZXItcHJlc2NyaXB0aW9uLW1lZGljaW5lLWluc3VyYW5jZS1obW8taGVhbHRoY2FyZS1nZXR0eS5qcGcmdz03MDA"/></p>
<p>图片来源：Getty Images。</p>
<h2>英格兰德将其基金在这只接近 12% 收益率的医疗股票上的持仓增加了 10 倍</h2>
<p>但当以色列·英格兰德将全球最热门的 AI 股票抛售时，他却忙于购买药品连锁店 <strong>沃尔格林联合博姿</strong>（Walgreens Boots Alliance），该股票的交易水平是 20 世纪末的水平，收益率超过 11.5%！</p>
<p>在截至九月的季度中，英格兰德的基金购买了 5,138,342 股沃尔格林的股票，使其持仓在短短三个月内增加了惊人的 953%！值得注意的是，千禧管理公司通常通过认沽和认购期权对其普通股持仓进行对冲，这在英伟达和沃尔格林联合博姿的情况下也是如此。</p>
<p>说沃尔格林面临挑战简直是轻描淡写。它正面临来自 <strong>Amazon</strong> 等在线药房日益增长的压力，在努力成为一家医疗服务公司的过程中遭遇了复杂情况（即大额减记），甚至在某些市场的运营结果也受到盗窃的负面影响。</p>
<p>尽管面临这些挑战，沃尔格林联合公司自历史最高点以来股价已下跌超过 90%，但 Englander 和他的团队依然加大了投资。</p>
<p>沃尔格林的主要催化剂之一是 2023 年 10 月任命 Tim Wentworth 为首席执行官。前首席执行官 Rosalind Brewer 是一位经验丰富的零售领袖，但缺乏医疗保健经验，而 Wentworth 则带来了数十年的医疗领导经验。尽管他的快速改革方式让华尔街和投资者感到震惊，但他并不避讳地阐述沃尔格林的长期愿景。</p>
<p>目前，公司专注于降低成本，并推动更高利润率的项目。计划在未来三个财政年度内关闭大约 8,500 家美国门店中的 1,200 家，这将降低运营费用，并将公司的努力集中在更高机会的领域。</p>
<p>此外，Wentworth 打算继续推动其医疗服务转型。尽管与 VillageMD 的合作及投资导致了大额减记，但沃尔格林的首席执行官相信，公司正朝着其共设初级护理诊所的可持续盈利能力迈进。</p>
<p>截至目前，沃尔格林联合公司的收益率几乎达到了不可思议的 11.5%。然而，考虑到沃尔格林正在进行成本削减，并试图进行多年的转型，如果这一分红再次被削减或完全搁置以保留现金，也并不令人惊讶。</p>
<p>虽然我确实相信沃尔格林联合公司具备实现转型的工具，但这将是一个缓慢的过程，充满了许多坑洼和障碍。</p>

沃尔格林联合博姿

英伟达

<p>亿万富翁以色列·英格兰德（Israel Englander）已出售米伦尼姆管理公司（Millennium Management）在英伟达（Nvidia）中的 70% 股份，将其持股减少至 1115 万股。这一决定是在对英伟达毛利率下降和人工智能领域竞争加剧的担忧中做出的。同时，英格兰德正在大举投资沃尔格林联合博姿（Walgreens Boots Alliance），这是一只近 12% 股息收益率的医疗保健股票，表明他在潜在的人工智能股票波动中正向更稳定的投资方向转变</p>

<p>Less than two weeks ago, Wall Street and investors were privy to one of the most important data releases of the fourth quarter -- and <em>no</em>, I'm not talking about the October inflation report.</p>
<div class="lb-trans"><p>不到两周前，华尔街和投资者获得了第四季度最重要的数据发布之一——不，我不是在说十月份的通胀报告。</p>
</div><p>No later than 45 days following the end to a quarter, institutional investors with at least $100 million in assets under management (AUM) are required to file Form 13F with the Securities and Exchange Commission. A 13F offers a way for everyday investors to track which stocks Wall Street's leading money managers have been purchasing and selling during the previous quarter (in this instance, the September-ended quarter).</p>
<div class="lb-trans"><p>在一个季度结束后的 45 天内，管理资产至少为 1 亿美元的机构投资者必须向证券交易委员会提交 13F 表格。13F 为普通投资者提供了一种跟踪华尔街顶级资金经理在上一个季度（在这种情况下是截至九月的季度）购买和出售哪些股票的方式。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy83OTg4NTEvbW9uZXktbWFuYWdlci1zdG9jay1jaGFydC1tYXJrZXQtbGV2ZWwtMi1kYXRhLWludmVzdC1nZXR0eS5qcGcmdz03MDA" alt="" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F798851%2Fmoney-manager-stock-chart-market-level-2-data-invest-getty.jpg&amp;op=resize&amp;w=700"/></p>
<p>Image source: Getty Images.</p>
<div class="lb-trans"><p>图片来源：Getty Images。</p>
</div><p>While the highlight of 13F filing season tends to be Warren Buffett's <strong>Berkshire Hathaway</strong>, there is no shortage of billionaire investors who've dazzled Wall Street over the years. Billionaire Israel Englander of Millennium Management, who oversees close to $211 billion in AUM spread across thousands of securities (common stock and options), is a perfect example.</p>
<div class="lb-trans"><p>虽然 13F 申报季的亮点往往是沃伦·巴菲特的 <strong>伯克希尔哈撒韦</strong>，但多年来在华尔街上令人瞩目的亿万富翁投资者并不少见。亿万富翁以色列·英格兰德（Israel Englander）是千禧管理公司（Millennium Management）的创始人，管理着近 2110 亿美元的资产，分散在数千种证券（普通股和期权）中，是一个完美的例子。</p>
</div><p>Among the thousands of transactions made by Englander and his top advisors, two contrarian trades stand out. In one respect, Englander has been a decisive seller of Wall Street's premier artificial intelligence (AI) stock, <strong>Nvidia</strong>(NVDA -4.18%). Comparatively, he's been piling into a struggling healthcare stock whose dividend yield is approaching a scorching-hot 12%!</p>
<div class="lb-trans"><p>在英格兰德及其顶级顾问进行的数千笔交易中，有两笔逆向交易尤为突出。在某种程度上，英格兰德一直是华尔街顶级人工智能（AI）股票 <strong>英伟达</strong>（Nvidia）的果断卖家。相比之下，他则在大量购买一只挣扎中的医疗保健股票，该股票的股息收益率接近火热的 12%！</p>
</div><h2>Englander's Millennium rings the register on over two-thirds of its Nvidia stock</h2>
<div class="lb-trans"><h2>英格兰德的千禧管理公司出售超过三分之二的英伟达股票</h2>
</div><p>Since the page turned to 2023, AI colossus Nvidia has been virtually unstoppable. Shares are up 871%, as of the closing bell on Nov. 22, with the company's market value climbing by north of $3.1 trillion. Wall Street has never witnessed a market-leading business increase in value so quickly before. Perhaps this has been the impetus behind Millennium's selling spree.</p>
<div class="lb-trans"><p>自 2023 年开始以来，人工智能巨头英伟达几乎势不可挡。截至 11 月 22 日收盘，股价上涨了 871%，公司的市值超过 3.1 万亿美元。华尔街从未见过如此迅速增长的市场领先企业。也许这就是千禧管理公司出售股票的动力。</p>
</div><p>Based on 13F filings, Englander's fund has sold 26,371,575 split-adjusted shares of Nvidia over the trailing year, ended Sept. 30. The &#34;split-adjusted&#34; aspect pertains to Nvidia conducting a historic 10-for-1 forward stock split following the close of trading on June 7. Millennium's remaining 11.15 million shares of Nvidia means its position has been slashed by 70% in a year.</p>
<div class="lb-trans"><p>根据 13F 申报，英格兰德的基金在截至 9 月 30 日的过去一年中出售了 26,371,575 股经过拆分调整的英伟达股票。这里的 “拆分调整” 是指英伟达在 6 月 7 日交易结束后进行了一次历史性的 10 比 1 的股票拆分。千禧管理公司剩余的 1115 万股英伟达股票意味着其持仓在一年内减少了 70%。</p>
</div><p>The wind in Nvidia's sails has been fueled by its dominance in AI-accelerated data centers. Demand for the company's H100 graphics processing unit (GPU) and next-generation Blackwell chip has overwhelmed supply, leading to exceptional pricing power and a jaw-dropping gross margin of 74.6%, as of the end of the fiscal third quarter (Oct. 27, 2024).</p>
<div class="lb-trans"><p>英伟达的成功得益于其在 AI 加速数据中心的主导地位。该公司的 H100 图形处理单元（GPU）和下一代 Blackwell 芯片的需求超出了供应，导致了卓越的定价能力和惊人的 74.6% 的毛利率，截至 2024 财年第三季度（10 月 27 日）。</p>
</div><p>What's more, Nvidia's GPUs have proven collectively superior to competing hardware in terms of computing capacity. Between Nvidia's CUDA software platform keeping customers loyal to its ecosystem and its GPUs outperforming on a computing basis, it's had little trouble outpacing Wall Street's already lofty consensus growth forecasts.</p>
<div class="lb-trans"><p>更重要的是，英伟达的 GPU 在计算能力方面证明了其整体优越性。由于英伟达的 CUDA 软件平台使客户忠于其生态系统，并且其 GPU 在计算性能上表现优异，因此它在超越华尔街已经高涨的共识增长预测方面没有遇到太大困难。</p>
</div><p>But there may be a perfect storm brewing for Nvidia, which might explain Englander's persistent selling activity in Wall Street's AI darling.</p>
<div class="lb-trans"><p>但对于英伟达来说，可能正在酝酿一场完美风暴，这或许可以解释英格兰德在华尔街的 AI 宠儿中持续的卖出活动。</p>
</div><p>One of the biggest clues that Nvidia's stock has topped is its gross margin. While AI-GPU scarcity and higher price points for its H100 sent the company's gross margin soaring to more than 78% in the fiscal first quarter, it's subsequently retraced to 75.1% in the second quarter and 74.6% in the latest quarter. Nvidia's forecast for the fiscal fourth quarter pegs its gross margin between 73% and 73.5%, +/- 50 basis points. This steady decline in gross margin would imply that AI-GPU scarcity is waning, along with Nvidia's pricing power.</p>
<div class="lb-trans"><p>英伟达股票见顶的一个重要线索是其毛利率。虽然 AI-GPU 的稀缺性和 H100 的高价使公司的毛利率在财年第一季度飙升至超过 78%，但随后在第二季度回落至 75.1%，在最新季度降至 74.6%。英伟达对财年第四季度的预测将其毛利率定在 73% 到 73.5% 之间，波动幅度为±50 个基点。这一毛利率的持续下降意味着 AI-GPU 的稀缺性正在减弱，英伟达的定价能力也在下降。</p>
</div><p>Competition is also coming at Nvidia from all angles. Though direct competitors, such as <strong>Advanced Micro Devices</strong>, garner most of the attention, the greater threat to Nvidia's data center &#34;real estate&#34; arguably comes from within. Many of its top customers by net sales, which are members of the &#34;Magnificent Seven,&#34; are internally developing AI-GPUs to use in their data centers. Even with Nvidia's chips possessing computing advantages, these internally developed chips are cheaper and more easily accessible.</p>
<div class="lb-trans"><p>竞争也从各个角度向英伟达袭来。尽管 <strong>超微半导体</strong>（Advanced Micro Devices）等直接竞争对手获得了大部分关注，但对英伟达数据中心 “房地产” 的更大威胁可能来自内部。许多按净销售额计算的顶级客户，属于 “七大奇迹” 之一，正在内部开发 AI-GPU 以在其数据中心使用。即使英伟达的芯片在计算能力上具有优势，这些内部开发的芯片也更便宜且更易于获取。</p>
</div><p>History might be the other catalyst that's encouraged Englander to cash in his chips. At no point over the last three decades have we witnessed a potentially game-changing technology avoid an early stage bubble. The internet, genome decoding, 3D printing, and the metaverse are just some of the examples of highly touted advancements where investors overestimated their early stage utility and adoption. If history were to rhyme and the artificial intelligence bubble bursts, no company would take it on the chin more than Nvidia.</p>
<div class="lb-trans"><p>历史可能是促使英格兰德兑现收益的另一个催化剂。在过去三十年中，我们从未见过任何可能改变游戏规则的技术避免早期泡沫。互联网、基因解码、3D 打印和元宇宙只是一些备受推崇的进步的例子，投资者高估了它们在早期阶段的实用性和采用率。如果历史重演，人工智能泡沫破裂，没有哪家公司会比英伟达更受影响。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy83OTg4NTEvcGhhcm1hY3ktY3VzdG9tZXItcHJlc2NyaXB0aW9uLW1lZGljaW5lLWluc3VyYW5jZS1obW8taGVhbHRoY2FyZS1nZXR0eS5qcGcmdz03MDA" alt="" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F798851%2Fpharmacy-customer-prescription-medicine-insurance-hmo-healthcare-getty.jpg&amp;op=resize&amp;w=700"/></p>
<p>Image source: Getty Images.</p>
<div class="lb-trans"><p>图片来源：Getty Images。</p>
</div><h2>Englander just 10X'd his fund's stake in this nearly 12%-yielding healthcare stock</h2>
<div class="lb-trans"><h2>英格兰德将其基金在这只接近 12% 收益率的医疗股票上的持仓增加了 10 倍</h2>
</div><p>But while Israel Englander has been sending shares of the hottest AI stock on the planet to the chopping block, he's been busy purchasing shares of pharmacy chain <strong>Walgreens Boots Alliance</strong>(WBA 4.62%), which is trading at levels last observed in the late 20th century and yielding more than 11.5%!</p>
<div class="lb-trans"><p>但当以色列·英格兰德将全球最热门的 AI 股票抛售时，他却忙于购买药品连锁店 <strong>沃尔格林联合博姿</strong>（Walgreens Boots Alliance），该股票的交易水平是 20 世纪末的水平，收益率超过 11.5%！</p>
</div><p>During the September-ended quarter, Englander's fund bought 5,138,342 shares of Walgreens, which increased its position by a whopping 953% in just three months! It should be noted that Millennium commonly hedges its common-stock holdings with put and call options, which is the case with both Nvidia and Walgreens Boots Alliance.</p>
<div class="lb-trans"><p>在截至九月的季度中，英格兰德的基金购买了 5,138,342 股沃尔格林的股票，使其持仓在短短三个月内增加了惊人的 953%！值得注意的是，千禧管理公司通常通过认沽和认购期权对其普通股持仓进行对冲，这在英伟达和沃尔格林联合博姿的情况下也是如此。</p>
</div><p>To say that things have been challenging for Walgreens would be nothing short of an understatement. It's facing growing online pharmacy pressure from the likes of <strong>Amazon</strong>, has endured complications (i.e., sizable writedowns) in its efforts to become a healthcare-services company, and has even had its operating results negatively impacted in select markets by theft.</p>
<div class="lb-trans"><p>说沃尔格林面临挑战简直是轻描淡写。它正面临来自 <strong>Amazon</strong> 等在线药房日益增长的压力，在努力成为一家医疗服务公司的过程中遭遇了复杂情况（即大额减记），甚至在某些市场的运营结果也受到盗窃的负面影响。</p>
</div><p>Despite these challenges, which have slashed Walgreens Boots Alliance's share price by more than 90% since it hit an all-time high, Englander and his team have piled in.</p>
<div class="lb-trans"><p>尽管面临这些挑战，沃尔格林联合公司自历史最高点以来股价已下跌超过 90%，但 Englander 和他的团队依然加大了投资。</p>
</div><p>One of the primary catalysts for Walgreens was the appointment of Tim Wentworth as CEO in October 2023. Whereas prior CEO Rosalind Brewer was a seasoned retail leader but lacked healthcare experience, Wentworth brings decades of healthcare leadership to the table. While his rip-off-the-Band-Aid approach has been a bit of a shock to Wall Street and investors, he's not been shy about laying out his long-term vision for Walgreens.</p>
<div class="lb-trans"><p>沃尔格林的主要催化剂之一是 2023 年 10 月任命 Tim Wentworth 为首席执行官。前首席执行官 Rosalind Brewer 是一位经验丰富的零售领袖，但缺乏医疗保健经验，而 Wentworth 则带来了数十年的医疗领导经验。尽管他的快速改革方式让华尔街和投资者感到震惊，但他并不避讳地阐述沃尔格林的长期愿景。</p>
</div><p>For the moment, the company is focused on bringing down costs, as well as promoting higher-margin initiatives. The plan is to close 1,200 of its roughly 8,500 U.S. stores over the next three fiscal years, which will lower its operating expenses and focus the company's efforts on areas of higher opportunity.</p>
<div class="lb-trans"><p>目前，公司专注于降低成本，并推动更高利润率的项目。计划在未来三个财政年度内关闭大约 8,500 家美国门店中的 1,200 家，这将降低运营费用，并将公司的努力集中在更高机会的领域。</p>
</div><p>Furthermore, Wentworth intends to keep promoting its healthcare-services transition. Even though its partnership with and investment in VillageMD has led to sizable writedowns, Walgreens' chief believes the company is moving toward recurring profitability from its co-located primary care clinics.</p>
<div class="lb-trans"><p>此外，Wentworth 打算继续推动其医疗服务转型。尽管与 VillageMD 的合作及投资导致了大额减记，但沃尔格林的首席执行官相信，公司正朝着其共设初级护理诊所的可持续盈利能力迈进。</p>
</div><p>As of this writing, Walgreens Boots Alliance is yielding an almost unfathomable 11.5%. However, with Walgreens in cost-cutting mode and the company attempting a multiyear turnaround, it wouldn't be surprising if this payout was cut again or shelved entirely to preserve cash.</p>
<div class="lb-trans"><p>截至目前，沃尔格林联合公司的收益率几乎达到了不可思议的 11.5%。然而，考虑到沃尔格林正在进行成本削减，并试图进行多年的转型，如果这一分红再次被削减或完全搁置以保留现金，也并不令人惊讶。</p>
</div><p>While I do believe Walgreens Boots Alliance has the tools to effect a turnaround, it's going to be a slow process filled with plenty of potholes and speed bumps.</p>
<div class="lb-trans"><p>虽然我确实相信沃尔格林联合公司具备实现转型的工具，但这将是一个缓慢的过程，充满了许多坑洼和障碍。</p>
</div>

Billionaire Israel Englander Sold 70% of Millennium's Stake in Nvidia and Is Piling Into a Supercharged Dividend Stock With a Nearly 12% Yield

- 英国亿万富翁以色列·英格兰德在出售 Nvidia 股票的同时，增持 Walgreens Boots Alliance。  
- 英格兰德的基金在过去一年内减持 Nvidia 股票 70%，而 Walgreens 的持股增加了 953%。  
- Walgreens 在新 CEO 的领导下，计划关闭 1200 家门店以降低成本并转型。  

亿万富翁以色列·英格兰德出售了千禧基金在英伟达的 70% 股份，并正在大量买入一个收益率接近 12% 的高分红股票